Cargando…
Overlap of Thrombotic Microangiopathy and Mesangial Proliferative Glomerulonephritis Caused by Combination Therapy with Atezolizumab and Bevacizumab
Vascular endothelial growth factor inhibitors and checkpoint inhibitors are effective treatments for solid tumors. These new classes of anti-cancer agents frequently cause kidney-related side effects. Although their anti-cancer effects may be enhanced when used in combination, the severity of their...
Autores principales: | Horino, Taro, Eguchi, Tomohiro, Inotani, Satoshi, Hirose, Akira, Ishihara, Masayuki, Yagyu, Kenichi, Uchida, Kazushige, Fujieda, Mikiya, Terada, Yoshio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9876725/ https://www.ncbi.nlm.nih.gov/pubmed/35705272 http://dx.doi.org/10.2169/internalmedicine.9425-22 |
Ejemplares similares
-
Fibrillary Glomerulonephritis with Crescentic and Necrotizing Glomerulonephritis and Concurrent Thrombotic Microangiopathy
por: Tsui, Calvin, et al.
Publicado: (2018) -
Progressive bevacizumab-associated renal thrombotic microangiopathy*
por: Uy, Alice L., et al.
Publicado: (2009) -
Warfarin-Related Nephropathy Manifested as Diffuse Mesangial Proliferative Glomerulonephritis
por: Acquah, Frederick, et al.
Publicado: (2022) -
Overhanging Edge Bone Erosion in Chronic Tophaceous Gout
por: Horino, Taro, et al.
Publicado: (2020) -
Atypical presentation of post infectious glomerulonephritis as malignant hypertension and thrombotic microangiopathy
por: Vankalakunti, M., et al.
Publicado: (2014)